Abstract
Multi-drug resistance of breast cancer is a major obstacle in chemotherapy of cancer treatments. Recently it was suggested that photodynamic therapy (PDT) can overcome drug resistance of tumors. ALA-PDT is based on the administration of 5-aminolevulinic acid (ALA), the natural precursor for the PpIX biosynthesis, which is a potent natural photosensitizer. In the present study we used the AlaAcBu, a multifunctional ALA-prodrug for photodynamic inactivation of drug resistant MCF-7/DOX breast cancer cells. Supplementation of low doses (0.2mM) of AlaAcBu to the cells significantly increased accumulation of PpIX in both MCF-7/WT and MCF-7/DOX cells in comparison to ALA, or ALA + butyric acid (BA). In addition, our results show that MCF-7/DOX cells are capable of producing higher levels of porphyrins than MCF-7/WT cells due to low expression of the enzyme ferrochelatase, which inserts iron into the tetra-pyrrol ring to form the end product heme. Light irradiation of the AlaAcBu treated cells activated efficient photodynamic killing of MCF-7/DOX cells similar to the parent MCF-7/WT cells, depicted by low mitochondrial enzymatic activity, LDH leakage and decreased cell survival following PDT. These results indicate that the pro-drug AlaAcBu is an effective ALA derivative for PDT treatments of multidrug resistant tumors.
Similar content being viewed by others
References
S. T. Wong and S. Goodin, Overcoming drug resistance in patients with metastatic breast cancer, Pharmacotherapy, 2009, 29, 954–65.
S. Germano and L. O’Driscoll, Breast cancer: understanding sensitivity and resistance to chemotherapy and targeted therapies to aid in personalised medicine, Curr. Cancer Drug Targets, 2009, 9, 398–418.
J. Hurtig, Managing patients with advanced and metastatic breast cancer, Clin. J. Oncol. Nurs., 2010, 14, 313–23.
S. Moore, Cutaneous metastatic breast cancer, Clin. J. Oncol. Nurs., 2002, 6, 255–60.
M. A. Capella and L. S. Capella, A light in multidrug resistance: photodynamic treatment of multidrug-resistant tumors, J. Biomed. Sci., 2003, 10, 361–6.
P. Ponka, Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells, Blood, 1997, 89, 1–25.
J. Kulbacka, A. Chwilkowska, J. Bar, A. Pola, T. Banas, A. Gamian and J. Saczko, Oxidative alterations induced in vitro by the photodynamic reaction in doxorubicin-sensitive (LoVo) and -resistant (LoVoDX) colon adenocarcinoma cells, Exp. Biol. Med., 2010, 235, 98–110.
K. Kusuzaki, G. Minami, H. Takeshita, H. Murata, S. Hashiguchi, T. Nozaki, T. Ashihara and Y. Hirasawa, Photodynamic inactivation with acridine orange on a multidrug-resistant mouse osteosarcoma cell line, Cancer Sci., 2000, 91, 439–45.
W. Li, W. J. Zhang, K. Ohnishi, I. Yamada, R. Ohno and K. Hashimoto, 5-Aminolaevulinic acid-mediated photodynamic therapy in multidrug resistant leukemia cells, J. Photochem. Photobiol., B, 2001, 60, 79–86.
T. Tsai, R. L. Hong, J. C. Tsai, P. J. Lou, I. F. Ling and C. T. Chen, Effect of 5-aminolevulinic acid-mediated photodynamic therapy on MCF-7 and MCF-7/ADR cells, Lasers Surg. Med., 2004, 34, 62–72.
M. H. Teiten, L. Bezdetnaya, J. L. Merlin, C. Bour-Dill, M. E. Pauly, M. Dicato and F. Guillemin, Effect of metatetra(hydroxyphenyl)chlorin (mTHPC)-mediated photodynamic therapy on sensitive and multidrug-resistant human breast cancer cells, J. Photochem. Photobiol., B, 2001, 62, 146–52.
P. M. Tang, D. M. Zhang, N. H. Xuan, S. K. Tsui, M. M. Waye, S. K. Kong, W. P. Fong and K. P. Fung, Photodynamic therapy inhibits P-glycoprotein mediated multidrug resistance via JNK activation in human hepatocellular carcinoma using the photosensitizer pheophorbide a, Mol. Cancer, 2009, 8 56.
G. Berkovitch, D. Doron, A. Nudelman, Z. Malik and A. Rephaeli, Novel multifunctional acyloxyalkyl ester prodrugs of 5-aminolevulinic acid display improved anticancer activity independent and dependent on photoactivation, J. Med. Chem., 2008, 51, 7356–69.
N. Grunberg-Etkovitz, L. Greenbaum, B. Grinblat and Z. Malik, Proteasomal degradation regulates expression of porphobilinogen deaminase (PBGD) mutants of acute intermittent porphyria, Biochim. Biophys. Acta, Mol. Basis Dis., 2006, 1762, 819–827.
T. L. Hanna, D. N. Dietzler, C. H. Smith, S. Gupta and H. S. Zarkowsky, Erythrocyte porphyrin analysis in the detection of lead poisoning in children: evaluation of four micromethods, Clin. Chem., 1976, 22, 161–8.
A. Orenstein, G. Kostenich and Z. Malik, The kinetics of protoporphyrin fluorescence during ALA-PDT in human malignant skin tumors, Cancer Lett., 1997, 120, 229–34.
W. Kemmner, K. Wan, S. Rüttinger, B. Ebert, R. Macdonald, U. Klamm and K. T. Moesta, Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer, FASEBJ., 2008, 22(2), 500–9.
R. Jendzelovsky, J. Mikes, J. Koval, K. Soucek, J. Prochazkova, M. Kello, V. Sackova, J. Hofmanova, A. Kozubik and P. Fedorocko, Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells, Photochem. Photobiol. Sci., 2009, 8, 1716–23.
M. Comporti, C. Signorini, S. Leoncini, C. Gardi, L. Ciccoli, A. Giardini, D. Vecchio and B. Arezzini, Ethanol-induced oxidative stress: basic knowledge, Genes Nutr., 2010, 5, 101–109.
H. K. Seitz and N. Homann, The role of acetaldehyde in alcoholassociated cancer of the gastrointestinal tract Novartis, Novartis Found. Symp., 2007, 285, 110–119.
E. Blake and A. Curnow, The hydroxypyridinone iron chelator CP94 can enhance PpIX-induced PDT of cultured human glioma cells, Photochem. Photobiol., 2010, 86(5), 1154–60.
J. Hanania and Z Malik, The effect of EDTA and serum on endogenous-porphyrin accumulation and photodynamic sensitization of human K562 leukemic cells, Cancer Lett., 1992, 65, 127–131.
Y. Ohgari, Y. Nakayasu, S. Kitajima, M. Sawamoto, H. Mori, O. Shimokawa, H. Matsui and S. Taketani, Mechanisms involved in delta-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin, Biochem. Pharmacol., 2005, 1971(1-2), 42–9.
G. P. Lewis, Method using ortho-tolidine for the quantitative determination of haemoglobin in serum and urine, J. Clin. Pathol., 1965, 18, 235–239.
E. Buytaert, M. Dewaele and P. Agostinis, Molecular effectors of multiple cell death pathways initiated by photodynamic therapy, Biochim. Biophys. Acta, 2007, 1776, 86–107.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Feuerstein, T., Berkovitch-Luria, G., Nudelman, A. et al. Modulating ALA-PDT efficacy of mutlidrug resistant MCF-7 breast cancer cells using ALA prodrug. Photochem Photobiol Sci 10, 1926–1933 (2011). https://doi.org/10.1039/c1pp05205e
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1039/c1pp05205e